Rapport Therapeutics, Inc. (RAPP)
↓ Download CSVKey ratios (FY2025)
-23.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$125.10M | -$83.06M | -$36.18M | — |
| Net Income | -$111.48M | -$78.31M | -$34.79M | — |
| EPS (Diluted) | $-2.86 | $-3.78 | $-23.10 | — |
| Total Assets | $512.43M | $314.93M | $155.42M | — |
| Total Liabilities | $27.78M | $9.51M | $14.48M | — |
| Shareholders' Equity | $484.65M | $305.43M | -$25.63M | -$10.06M |
| Cash & Equivalents | $52.65M | $56.80M | $70.17M | — |
| Operating Cash Flow | -$87.47M | -$64.83M | -$27.18M | — |
| Capital Expenditures | $616.0K | $2.40M | $1.64M | — |
| Shares Outstanding | 47.77M | 36.58M | 4.17M | — |